CancerCare Center | Cancer Research

Trinity CancerCare Center: Cancer Research

Clinical Trials in CancerCare:

Trinity CancerCare offers a variety of research trials that patients have the ability to access. These research trials are essential for moving new options for preventing, diagnosing, and treating cancer from the laboratory setting to the clinic office. Below is a listing of the clinical research trials currently open for patient accrual at Trinity CancerCare Center.

Breast Cancer:

  • BCCR: Development and implementation of the Breast Cancer Collaborative Registry: NCT00666731

  • E1Z11: A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): NCT01824836

  • E2112: A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer: NCT02115282

  • S1207: Adjuvant everolimus for high risk hormone receptor‐positive and HER2‐negative breast cancer, randomized clinical trial of standard adjuvant endocrine therapy +/‐ chemotherapy in patients with negative breast cancer with recurrence score (RS) of 25 or less: NCT01674140

  • NRG-BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide followed by weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative invasive Breast CancerA: NCT02488967

Lung Cancer:

  • CALGB 30610: Phase III Comparison Of Thoracic Radiotherapy Regimens In Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin And Etoposide: NCT00632853

  • S1400: Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer: NCT02154490

Hematological Cancer:

  • Currently no open trials

Gastrointestinal Cancer:

  • S0820: A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES): NCT01349881

Head & Neck Cancer:

  • Currently no open trials

Genitourinary Cancer:

  • A031201: Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer: NCT01949337

  • S0931: EVEREST: Everolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study: NCT01120145

Brain Cancer:

  • A071102: A Phase II/III Randomized Trial of Veliparib or Placebo in combination with Adjuvant Temozolomide in newly diagnosed Glioblastoma with MGMT Promoter Hypermethylation: NCT02152982

Multiple Myeloma:

  • Currently no open trials.

Cancer with Bone Metastases:

  • Currently no open trials.

Contact Information for Cancer Research Trials:

Pamela Brewer, RN
Cancer Research Nurse
(701) 857-3174


 Providers in this field:
 (hover or click to view more details)

Michael Grant MD

Board certified in Radiation Oncology. Additional information being updated. --More--

Pamela Holwegner FNP-C, AOCNP

A certified nurse practitioner, Pamela Holwegner, FNP-C, AOCNP provides care as a member of Trinity --More--

Stephen Makoni MD, FACP

As a specialist in Hematology and Oncology, Dr. Makoni provides expert care for cancer patients util --More--

Ebony Peterson FNP-BC

A member of our cancer care team, Ebony Peterson, FNP-BC, provides care and support to patients unde --More--

Patanit Watanaboonyakhet DO

Dr. Patanit Watanaboonyakhet ("Dr. Pat") specializes in Hematology and Oncology. A graduate of the U --More--